Search results for: NHS Expenditure
Filter search results
The Pros and Cons of Modelling in Economic Evaluation
1 May 1997
…Economics, University of York, UK Dr Bryan Luce. Chief Executive of MEDTAP International, USA Professor Trevor Sheldon. Director of the NHS Centre for Reviews and Dissemination, University of York, UK…
GP Commissioning Groups – The Nottingham Experience
1 December 1998
…lessons learned by the first wave fundholders to be passed on to subsequent waves. As from next April the whole of the NHS will be in the ‘first wave’ of…
The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries
5 January 2018
…payers see the potential for IBP to increase price competition in some indications, and the NHSE in England has used contracting by genotype in Hep C drug procurement to increase…
Bernarda Zamora
18 June 2024
…Bernarda has completed research on Health Economics analysing the impact of provider diversity in the NHS on several aspects of quality measured from patient experience surveys and from hospital emergency…
Graham Cookson
24 April 2018
…sciences. He is best known for this work on the economics of staffing and skill mix in the English NHS, which was critical to the development of the NICE Guidelines…
Richard Torbett
3 February 2023
…policy (including the Voluntary Scheme for Medicine Policy and Access -VPAS); Health Technology Assessment as well as the organisation’s partnership activities with the NHS throughout the UK. Richard has spent…
Caring about Carers: Improving Consideration of the Burden of Informal Caring in HTA
11 April 2023
…of informal care is almost equivalent to the entire budget of the National Health Service (NHS). There are, however, many challenges around appropriately valuing these contributions, including how to value…
How Restrictive are NICE ‘Optimised’ Decisions?
27 April 2023
The National Institute for Health and Care Excellence (NICE) makes recommendations for the use of medicines in the National Health Service (NHS) in England based on their clinical and cost-effectiveness…
A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance
19 May 2023
…such as the NICE-NHS England pilot in the UK and the PASTEUR Act in the US, is a moment of opportunity to redefine how health technologies with a large impact…